173 related articles for article (PubMed ID: 18379015)
21. First report of monomicrobial Candida parapsilosis necrotizing fasciitis.
Gassiep I; Douglas J; Playford EG
Transpl Infect Dis; 2016 Oct; 18(5):752-755. PubMed ID: 27385469
[TBL] [Abstract][Full Text] [Related]
22. Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature.
Poon LM; Chia HY; Tan LK; Liu TC; Koh LP
Transpl Infect Dis; 2009 Apr; 11(2):160-6. PubMed ID: 19228346
[TBL] [Abstract][Full Text] [Related]
23. [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B].
Saitoh T; Matsushima T; Shimizu H; Osaki Y; Yamane A; Irisawa H; Yokohama A; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
Rinsho Ketsueki; 2008 Feb; 49(2):94-8. PubMed ID: 18341039
[TBL] [Abstract][Full Text] [Related]
24. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Pande A; Non LR; Romee R; Santos CA
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28099778
[TBL] [Abstract][Full Text] [Related]
25. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
Madureira A; Bergeron A; Lacroix C; Robin M; Rocha V; de Latour RP; Ferry C; Devergie A; Lapalu J; Gluckmana E; Socié G; Ghannoum M; Ribaud P
Int J Antimicrob Agents; 2007 Dec; 30(6):551-4. PubMed ID: 18029149
[TBL] [Abstract][Full Text] [Related]
26. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
27. Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.
López-Jiménez J; Duarte-Palomino R; Cabezudo E; Velasco-Martínez JJ; Sousa A; Odriozola J
Blood; 1997 May; 89(9):3491-2. PubMed ID: 9129061
[No Abstract] [Full Text] [Related]
28. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Ng KP; Colombo A; Finquelievich J; Barnes R; Wadula J;
J Clin Microbiol; 2008 Mar; 46(3):842-9. PubMed ID: 18199791
[TBL] [Abstract][Full Text] [Related]
29. Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.
Kiehl MG; Egerer G; Engelhardt M; Gross B
Mycoses; 2015 Feb; 58(2):76-81. PubMed ID: 25590660
[TBL] [Abstract][Full Text] [Related]
30. Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin.
Sim JP; Kho BC; Liu HS; Yung R; Chan JC
Hong Kong Med J; 2005 Apr; 11(2):120-3. PubMed ID: 15815067
[TBL] [Abstract][Full Text] [Related]
31. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
[TBL] [Abstract][Full Text] [Related]
32. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
Hakki M; Staab JF; Marr KA
Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
34. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of invasive candidiasis with caspofungin in a child with acute lymphoblastic leukemia.
Tragiannidis A; Papageorgiou T; Theodoridou A; Athanassiadou F; Vyzantiadis T; Kalogera A
Pediatr Blood Cancer; 2007 Sep; 49(3):366-7. PubMed ID: 16921516
[No Abstract] [Full Text] [Related]
36. Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
Girmenia C; Martino P; Cassone A
Blood; 1996 Jan; 87(2):838-9. PubMed ID: 8555510
[No Abstract] [Full Text] [Related]
37. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
38. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
39. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
